Literature DB >> 7674831

Reduced beta 2-receptor mediated vasodilation in African Americans.

L L Watkins1, J E Dimsdale, M G Ziegler.   

Abstract

It is well recognized that African Americans have a higher prevalence of cardiovascular disease than White Americans although the underlying mechanisms are not entirely understood. This study was perfumed to evaluate racial differences in the chronotropic and vasodilatory effects of the beta-receptor agonist, isoproterenol. We compared cardiovascular responses to intravenous infusion of isoproterenol in 27 African Americans and 27 White men and women. African Americans showed significantly smaller beta 2-receptor mediated falls in diastolic pressure than Whites. In contrast, isoproterenol produced similar increases in heart rate in both races. The findings suggest that African Americans have decreased beta 2-receptor mediated vasodilatory capacity, and may help explain the higher prevalence of hypertension and cardiovascular disease in African Americans compared to Whites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674831     DOI: 10.1016/0024-3205(95)02103-p

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Race and sex differences in cardiovascular α-adrenergic and β-adrenergic receptor responsiveness in men and women with high blood pressure.

Authors:  Andrew Sherwood; LaBarron K Hill; James A Blumenthal; Kristy S Johnson; Alan L Hinderliter
Journal:  J Hypertens       Date:  2017-05       Impact factor: 4.844

2.  GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES.

Authors:  C Hesse; J H Eisenach
Journal:  Curr Pharmacogenomics Person Med       Date:  2008-09

Review 3.  Evolution of blood pressure regulation in humans.

Authors:  J Hunter Young
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

Review 4.  Differences in hypertension between blacks and whites: an overview.

Authors:  Jane Lindhorst; Nichole Alexander; Juliet Blignaut; Brian Rayner
Journal:  Cardiovasc J Afr       Date:  2007 Jul-Aug       Impact factor: 1.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.